Search

everythinglearnresearchcommunity

for

Search:↓

DHT, a testosterone byproduct, causes male pattern baldness.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Flutamide reduces hair growth better but has more side effects.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Androgens prevent hair growth by changing Wnt signals in cells.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Men with Kennedy disease have less chance of hair loss.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Sex hormones affect brain injury differently in males and females.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.